PIRS - Pieris gains on milestone payment from Boston Pharma
2023-08-17 10:51:44 ET
More on Pieris Pharma
- Pieris sinks 60% as AstraZeneca halts mid-stage trial for Asthma candidate
- Pieris spikes 11% on data for gastric cancer candidate
- Pieris stock slumps ~15% after FY22 sees fall in revenue
- Pieris to get $5M as Seagen starts dosing in phase 1 trial of cancer drug
- Seeking Alpha’s Quant Rating on Pieris Pharmaceuticals
- Earnings data for Pieris Pharmaceuticals
For further details see:
Pieris gains on milestone payment from Boston Pharma